Gene · 53345
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease. | Biomedicines | 2023 | 37509567 | PubTator, text mining | PubMed |
| NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models. | Cancers (Basel) | 2023 | 37509384 | PubTator, text mining | PubMed |
| Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy. | J Transl Med | 2023 | 37507803 | PubTator, text mining | PubMed |
| Significant roles of potential genes and their mutations in nonalcoholic fatty liver disease. | Clin Exp Hepatol | 2023 | 37502439 | PubTator, text mining | PubMed |
| Effects of TM6SF2 rs58542926 polymorphism on hepatocellular lipids and insulin resistance in early type 2 diabetes. | Nutr Metab Cardiovasc Dis | 2023 | 37495452 | PubTator, text mining | PubMed |
| Identification and characterisation of a rare MTTP variant underlying hereditary non-alcoholic fatty liver disease. | JHEP Rep | 2023 | 37484212 | PubTator, text mining | PubMed |
| MAFLD: an optimal framework for understanding liver cancer phenotypes. | J Gastroenterol | 2023 | 37470858 | PubTator, text mining | PubMed |
| The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma. | Aliment Pharmacol Ther | 2023 | 37470344 | PubTator, text mining | PubMed |
| Nonalcoholic Fatty Liver Disease Incidence and Remission and Their Predictors During 7 Years of Follow-up Among Finns. | J Clin Endocrinol Metab | 2023 | 37463486 | PubTator, text mining | PubMed |
| The association of dietary phytochemical index and nonalcoholic fatty liver disease. | Food Sci Nutr | 2023 | 37457157 | PubTator, text mining | PubMed |
| Sweating it out: How physical activity can combat high genetic risk for nonalcoholic fatty liver disease. | Liver Int | 2023 | 37452506 | PubTator, text mining | PubMed |
| Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds. | Nutrients | 2023 | 37447164 | PubTator, text mining | PubMed |
| Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key. | Int J Mol Sci | 2023 | 37445895 | PubTator, text mining | PubMed |
| Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review. | Cancers (Basel) | 2023 | 37444477 | PubTator, text mining | PubMed |
| The efficacy of L-carnitine in patients with nonalcoholic steatohepatitis and concomitant obesity. | Lipids Health Dis | 2023 | 37438785 | PubTator, text mining | PubMed |
| Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis. | Acta Pharm Sin B | 2023 | 37425048 | PubTator, text mining | PubMed |
| MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population. | Front Endocrinol (Lausanne) | 2023 | 37424875 | PubTator, text mining | PubMed |
| Lean nonalcoholic fatty liver disease and sarcopenia. | Front Endocrinol (Lausanne) | 2023 | 37424859 | PubTator, text mining | PubMed |
| Long-term risk of a fatty liver in liver donors. | Ann Gastroenterol Surg | 2023 | 37416731 | PubTator, text mining | PubMed |
| Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients. | Clin Res Cardiol | 2023 | 37410163 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53345/papers?page=17